United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F. Street, NE
Washington,
D.C. 20549-6010
Attn:
Mr. Russell Mancuso
|
Re: |
Pressure
BioSciences, Inc.
|
1. |
Your
response to prior comment 3 implies that you believe there may be
circumstances before the shareholder vote on the proposal in which
you
would enter into a plan, arrangement or contract to offer the securities
subject to the proposal without distributing revised proxy materials
and
resoliciting proxies. Please provide us the authority on which you
rely to
support your belief.
|
Very
truly yours,
|
|
/s/
Steven R. London
|
|
Steven
R. London
|
cc:
|
Geoffrey
Kruczek, Esq.
Richard
T. Schumacher, President and Chief Executive Officer, Pressure
BioSciences, Inc.
Edward
H. Myles, Chief Financial Officer, Pressure BioSciences,
Inc.
|